Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TNK-tPA second-generation thrombolytic data

Phase II results with a new form of tPA, TNK-tPA, show that the agent given as a single intravenous injection

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE